您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2022, Vol. 60 ›› Issue (7): 83-88.doi: 10.6040/j.issn.1671-7554.0.2022.0296

• 临床医学 • 上一篇    下一篇

右美托咪定对30例体外循环患者肠道屏障损伤的影响

李锐1,石存现2,于翠翠2   

  1. 1. 潍坊医学院麻醉学院, 山东 潍坊 261053;2. 烟台毓璜顶医院麻醉科, 山东 烟台 264000
  • 发布日期:2022-07-27
  • 通讯作者: 于翠翠. E-mail:yhdyyhhf@126.com
  • 基金资助:
    国家自然科学基金(82002387)

Effects of dexmedetomidine on intestinal-related injury during cardiopulmonary bypass

LI Rui1, SHI Cunxian2, YU Cuicui2   

  1. 1. School of Anesthesiology, Weifang Medical University, Weifang 261053, Shandong, China;
    2. Department of Anesthesiology, Yantai Yuhuangding Hospital, Yantai 264000, Shandong, China
  • Published:2022-07-27

摘要: 目的 探讨右美托咪定(DEX)对体外循环患者肠道屏障损伤的影响。 方法 将60例行体外循环心脏手术患者随机分为DEX组和对照组,每组30例。DEX组给予DEX干预,对照组给予等容量生理盐水输注。每组于给药前(T0)、体外循环结束即刻(T1)、术后2 h(T2)、术后6 h(T3)、术后24 h(T4)采集静脉血,测定肠型脂肪酸结合蛋白(I-FABP)、内毒素(LPS)、白介素-6(IL-6)及白介素-10(IL-10)浓度。并记录两组患者术后首次排便时间、重症监护室驻留时间、住院时间、死亡率以及不良反应的发生。 结果 60例患者均完成了研究方案,未观察到死亡或严重并发症。同一组不同时间点血清I-FABP、LPS、IL-6、IL-10浓度差异具有统计学意义(P均<0.001),T1~T4点均较T0点高。两组间血清I-FABP、LPS、IL-6、IL-10浓度差异具有统计学意义(P=0.029;P=0.002;P=0.022;P=0.022);DEX组T1~T4点I-FABP、LPS、IL-6较对照组低,IL-10水平较对照组高。两组患者术后第一次排便时间、ICU驻留时间、住院时间差异无统计学意义(P均>0.05)。 结论 DEX能够减轻体外循环患者肠道屏障的损伤。

关键词: 体外循环, 右美托咪定, 肠道屏障功能, 内毒性血症, 炎症反应

Abstract: Objective To investigate the effects of dexmedetomidine(DEX)on the intestinal barrier injury in patients with cardiopulmonary bypass. Methods A total of 60 patients undergoing cardiopulmonary bypass cardiac surgery were randomly divided into DEX group(n=30)and control group(n=30). The DEX group was given DEX intervention and the control group was given saline infusion of the same volume. Venous blood samples were collected before administration(T0), immediately after cardiopulmonary bypass(T1), 2 hours after operation(T2), 6 hours after operation(T3)and 24 hours after operation(T4). The levels of intestinal fatty acid binding protein(I-FABP), endotoxin(LPS), interleukin-6(IL-6)and interleukin-10(IL-10)were measured. The first defecation time, intensive care unit stay time, hospital stay, mortality and adverse reactions of the two groups were recorded. Results All 60 patients completed the study protocol, and no death or serious complications were observed. The levels of serum I-FABP, LPS, IL-6 and IL-10 in either group at different time points were significantly different(P<0.001), and the levels at T1-T4 were higher than those at T0. The levels of serum I-FABP, LPS, IL-6 and IL-10 were significantly different between the two groups(P=0.029; P=0.002; P=0.022; P=0.022), and the levels of I-FABP, LPS, IL-6 in DEX group at T1-T4 were lower than those in control group, but the levels of IL-10 were higher than those in control group. There were no significant differences in the first defecation time, ICU stay time and hospital stay between the two groups(P>0.05). Conclusion DEX can alleviate the damage of intestinal barrier in patients with cardiopulmonary bypass.

Key words: Cardiopulmonary bypass, Dexmedetomidine, Gut barrier function, Endotoxemia, Inflammation

中图分类号: 

  • R614
[1] Featherstone PJ, Ball CM. The origins of cardiopulmonary bypass [J]. Anaesth Intensive Care, 2018, 46(4): 351-353.
[2] Akhtar MI, Gautel L, Lomivorotov V, et al. Multicenter international survey on cardiopulmonary bypass perfusion practices in adult cardiac surgery [J]. J Cardiothorac Vasc Anesth, 2021, 35(4): 1115-1124.
[3] Justus G, Walker C, Rosenthal LM, et al. Immunodepression after CPB: Cytokine dynamics and clinics after pediatric cardiac surgery- A prospective trial [J]. Cytokine, 2019, 122: 154018. doi: 10. 1016/j. cyto. 2017. 03. 017.
[4] Tsukamoto H, Takeuchi S, Kubota K, et al. Lipopolysaccharide(LPS)-binding protein stimulates CD14-dependent toll-like receptor 4 internalization and lps-induced tbk1-ikk-irf3 axis activation [J]. J Biol Chem, 2018, 93(26): 10186-10201.
[5] Hadley JS, Wang JE, Michaels LC, et al. Alterations in inflammatory capacity and TLR expression on monocytes and neutrophils after cardiopulmonary bypass [J]. Shock, 2007, 27(5): 466-473.
[6] Zhang GR, Peng CM, Liu ZZ, et al. The effect of dexmedetomidine on myocardial ischemia/reperfusion injury in patients undergoing cardiac surgery with cardiopulmonary bypass: a meta-analysis [J]. Eur Rev Med Pharmacol Sci, 2021, 25(23): 7409-7417.
[7] Unchiti K, Leurcharusmee P, Samerchua A, et al. The potential role of dexmedetomidine on neuroprotection and its possible mechanisms: evidence from in vitro and in vivo studies [J]. Eur J Neurosci, 2021, 54(9): 7006-7047.
[8] Yang J, Wu Y, Xu Y, et al. Dexmedetomidine resists intestinal ischemia-reperfusion injury by inhibiting TLR4/MyD88/NF-κB signaling [J]. J Surg Res, 2021, 260: 350-358. doi: 10. 1016/j. jss. 2020. 11. 041.
[9] Sun W, Li F, Wang X, et al. Effects of dexmedetomidine on patients undergoing laparoscopic surgery for colorectal cancer[J]. J Surg Res, 2021, 267: 687-694. doi: 10. 1016/j. jss. 2021. 06. 043.
[10] 刘浩, 鲁金钢, 赵鹏程, 等. 右美托咪定预处理对老年腹腔镜手术患者术后氧化应激水平及肠屏障功能的影响[J]. 中华全科医学, 2020, 8(4): 585-588 LIU Hao, LU Jingang, ZHAO Pengcheng, et al. Effects of dexmedetomidine preconditioning on postoperative oxidative stress and intestinal barrier function in elderly patients undergoing laparoscopy [J]. Zhonghua General Medicine, 2020, 8(4): 585-588.
[11] Druml W. Intestinal cross-talk: The gut as motor of multiple organ failure [J]. Med Klin Intensivmed Notfmed, 2018, 113(6): 470-477.
[12] Hess NR, Seese LM, Hong Y, et al. Gastrointestinal complications after cardiac surgery: Incidence, predictors, and impact on outcomes [J]. J Card Surg, 2021, 36(3): 894-901.
[13] Zenger S, Demir Piroglu I, Çevik A, et al. The importance of serum intestinal fatty acid-binding protein for the early diagnosis of acute mesenteric ischemia [J]. Ulus Travma Acil Cerrahi Derg, 2021, 27(3): 278-283.
[14] Su W, Li Y, Wang Y, et al. Correlation between 1-FABP, blood routine and grading of necrotising enterocolitis [J]. J Coll Physicians Surg Pak, 2021, 31(2): 238-239.
[15] Kong C, Li SM, Yang H, et al. Screening and combining serum biomarkers to improve their diagnostic performance in the detection of intestinal barrier dysfunction in patients after major abdominal surgery [J]. Ann Transl Med, 2019, 7(16): 388. doi: 10. 21037/atm. 2019. 07. 102.
[16] Nuzzo A, Guedj K, Curac S, et al. Accuracy of citrulline, I-FABP and D-lactate in the diagnosis of acute mesenteric ischemia [J]. Sci Rep, 2021, 11(1): 18929. doi: 10. 1038/s41598-021-98012-w.
[17] Brandenburg K, Schromm AB, Weindl G, et al. An update on endotoxin neutralization strategies in gram-negative bacterial infections [J]. Expert Rev Anti Infect Ther, 2021, 19(4): 495-517.
[18] Adamik B, Kübler A, Gozdzik A, et al. Prolonged cardiopulmonary bypass is a risk factor for intestinal ischaemic damage and endotoxaemia [J]. Heart Lung Circ, 2017, 26(7): 717-723.
[19] Ciesielska A, Matyjek M, Kwiatkowska K. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling [J]. Cell Mol Life Sci, 2021, 78(4): 1233-1261.
[20] Dong N, Li X, Xue C, et al. Astragalus polysaccharides alleviates LPS-induced inflammation via the NF-κB/MAPK signaling pathway [J]. J Cell Physiol, 2020, 235(7-8): 5525-5540.
[21] Uciechowski P, Dempke WCM. Interleukin-6: a masterplayer in the cytokine network [J]. Oncology, 2020, 98(3): 131-137.
[22] Fernandez-Santamaria R, Satitsuksanoa P. Engineered IL-10: A matter of affinity [J]. Allergy, 2022, 77(3): 1067-1069.
[23] Jia T, Xing Z, WangAnd H, et al. Protective effect of dexmedetomidine on intestinal mucosal barrier function in rats after cardiopulmonary bypass [J]. Exp Biol Med(Maywood), 2022, 247(6): 498-508.
[24] Pan S, Chen Y, Zhang X, et al. The JAK2/STAT3 pathway is involved in dexmedetomidine-induced myocardial protection in rats undergoing cardiopulmonary bypass [J]. Ann Transl Med, 2020, 8(7): 483. doi: 10.21037/atm.2020.03.67.
[25] Li J, Dou X, Li D, et al. Dexmedetomidine ameliorates post-cpb lung injury in rats by activating the PI3K/Akt pathway [J]. J Invest Surg, 2020, 33(6): 576-583.
[26] Aydin C, Bagcivan I, Gursoy S,et al. Altered spontaneous contractions of the ileum by anesthetic agents in rats exposed to peritonitis [J]. World J Gastroenterol, 2009, 15(13): 1620-1624.
[1] 周溪,黄霂晗,任玉洁,邱洋. 新型冠状病毒感染与天然免疫及炎症反应[J]. 山东大学学报 (医学版), 2021, 59(5): 15-21.
[2] 闵傲雪,朱天瑞,张凤,王冉冉,李晓红. A151对糖氧剥夺和脂多糖诱导的BV-2细胞极化的影响[J]. 山东大学学报 (医学版), 2021, 59(3): 1-9.
[3] 杨佳,张曼,陈凯明,曹曦. miR-146a经TLR4/MyD88途径加速巨噬细胞迁移所致动脉硬化的作用机制[J]. 山东大学学报 (医学版), 2021, 59(11): 1-7.
[4] 高金梅,黄映波,冯珍珍. 单核细胞趋化蛋白-1对67例全身炎症反应综合征患者的诊断价值[J]. 山东大学学报 (医学版), 2021, 59(10): 77-81.
[5] 车东阳,厉泉,陈善良,于建民,李敏,许莉,毕严斌,李培杰,刘天起. 心脏移植围术期右心功能不全与肺血管阻力的关系及处理[J]. 山东大学学报 (医学版), 2019, 57(5): 99-104.
[6] 郭配,李秀华,张晓韬,何天齐,朱梅佳,唐吉友,赵张宁,毛飞. 伴有睡眠障碍帕金森病患者的睡眠特征及其影响因素[J]. 山东大学学报 (医学版), 2018, 56(4): 76-80.
[7] 陈攀,蒋春霞,雷艺. 2型糖尿病患者外周血突触融合蛋白8表达与慢性炎症、糖脂代谢的相关性[J]. 山东大学学报 (医学版), 2018, 56(12): 26-32.
[8] 张栾,陈欧,栾云,朱晓波,陈元,王一彪. Gemigliptin对野百合碱诱导的肺动脉高压大鼠治疗作用及炎症因子的影响[J]. 山东大学学报(医学版), 2017, 55(5): 19-22.
[9] 孙鹏飞,孟晓,张凯,黎莉. 抵抗素样分子 β在动脉粥样硬化斑块稳定性中的作用[J]. 山东大学学报(医学版), 2016, 54(3): 1-4.
[10] 李少伟, 刘宗正, 刘春霞, 张焱如, 周欢敏. 葡萄籽原花青素对小鼠脂肪肝模型缺血再灌注造成的急性肝损伤的保护作用[J]. 山东大学学报(医学版), 2015, 53(9): 41-46.
[11] 李少伟, 刘宗正, 刘春霞, 张焱如, 周欢敏. 口服富氢水对小鼠脂肪肝缺血再灌注损伤的保护作用[J]. 山东大学学报(医学版), 2015, 53(1): 10-15.
[12] 韩潇, 刘锟, 史加海, 高福民, 尤庆生. 醒脑静在体外循环心脏手术中对脑功能的保护[J]. 山东大学学报(医学版), 2015, 53(1): 54-57.
[13] 郭松青, 方向志, 高巨, 葛亚丽. 右美托咪定对体外循环下心脏瓣膜置换术患者 心肌损伤的影响[J]. 山东大学学报(医学版), 2014, 52(S2): 20-22.
[14] 郝凤成1,2,苏中华1,3. 自噬在ox-LDL诱导炎症反应中的保护作用[J]. 山东大学学报(医学版), 2014, 52(4): 30-34.
[15] 苗玉连,武传龙,刘金波,张晓黎. 白藜芦醇对高脂饮食去卵巢肥胖大鼠脑组织炎症反应及海马Aβ1-42水平的影响[J]. 山东大学学报(医学版), 2013, 51(8): 17-21.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 马青源,蒲沛东,韩飞,王超,朱洲均,王维山,史晨辉. miR-27b-3p调控SMAD1对骨肉瘤细胞增殖、迁移和侵袭作用的影响[J]. 山东大学学报 (医学版), 2020, 1(7): 32 -37 .
[2] 索东阳,申飞,郭皓,刘力畅,杨惠敏,杨向东. Tim-3在药物性急性肾损伤动物模型中的表达及作用机制[J]. 山东大学学报 (医学版), 2020, 1(7): 1 -6 .
[3] 龙婷婷,谢明,周璐,朱俊德. Noggin蛋白对小鼠脑缺血再灌注损伤后学习和记忆能力与齿状回结构的影响[J]. 山东大学学报 (医学版), 2020, 1(7): 15 -23 .
[4] 李宁,李娟,谢艳,李培龙,王允山,杜鲁涛,王传新. 长链非编码RNA AL109955.1在80例结直肠癌组织中的表达及对细胞增殖与迁移侵袭的影响[J]. 山东大学学报 (医学版), 2020, 1(7): 38 -46 .
[5] 张宝文,雷香丽,李瑾娜,罗湘俊,邹容. miR-21-5p靶向调控TIMP3抑制2型糖尿病肾病小鼠肾脏系膜细胞增殖及细胞外基质堆积[J]. 山东大学学报 (医学版), 2020, 1(7): 7 -14 .
[6] 付洁琦,张曼,张晓璐,李卉,陈红. Toll样受体4抑制过氧化物酶体增殖物激活受体γ加重血脂蓄积的分子机制[J]. 山东大学学报 (医学版), 2020, 1(7): 24 -31 .
[7] 丁祥云,于清梅,张文芳,庄园,郝晶. 胰岛素样生长因子II在84例多囊卵巢综合征患者颗粒细胞中的表达和促排卵结局的相关性[J]. 山东大学学报 (医学版), 2020, 1(7): 60 -66 .
[8] 徐玉香,刘煜东,张蓬,段瑞生. 101例脑小血管病患者脑微出血危险因素的回顾性分析[J]. 山东大学学报 (医学版), 2020, 1(7): 67 -71 .
[9] 史爽,李娟,米琦,王允山,杜鲁涛,王传新. 胃癌miRNAs预后风险评分模型的构建与应用[J]. 山东大学学报 (医学版), 2020, 1(7): 47 -52 .
[10] 肖娟,肖强,丛伟,李婷,丁守銮,张媛,邵纯纯,吴梅,刘佳宁,贾红英. 两种甲状腺超声数据报告系统诊断效能的比较[J]. 山东大学学报 (医学版), 2020, 1(7): 53 -59 .